|Bid||1,413.60 x 0|
|Ask||1,415.20 x 0|
|Day's range||1,398.40 - 1,420.20|
|52-week range||1,190.80 - 1,619.20|
|Beta (5Y monthly)||0.40|
|PE ratio (TTM)||16.29|
|Earnings date||27 Oct 2021|
|Forward dividend & yield||0.80 (5.69%)|
|Ex-dividend date||19 Aug 2021|
|1y target est||1,644.50|
Dr. Anand Swaminathan, Emergency Medicine Physician in New Jersey, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
LONDON, July 29, 2021--GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps.
Sanofi (SNY) earnings and sales beat estimates in the second quarter of 2021. Dupixent and vaccines drive sales growth in the reported quarter.